Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets (Parentheticals)

v3.24.1.1.u2
Consolidated Balance Sheets (Parentheticals)
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2024
₪ / shares
Dec. 31, 2023
USD ($)
shares
Statement of Financial Position [Abstract]      
Accounts receivable, net of allowance for credit losses (in Dollars) | $ $ 1,455,000   $ 1,449,000
Ordinary shares, nominal value (in Dollars per share) | ₪ / shares   ₪ 0.01  
Ordinary shares, authorized 180,000,000    
Ordinary shares, outstanding 70,440,000   69,656,000